Decision Diagnostics Stock

Decision Diagnostics EBIT

The EBIT of Decision Diagnostics (DECN) as of Aug 10, 2026 is -2.10 M USD. In the previous year, EBIT was -1.29 M USD — a change of 62.35% (lower).

EBIT

-2.10 MUSD

YoY

62.35%

Last updated:

In 2026, Decision Diagnostics's EBIT was -2.10 M USD, a 62.35% increase from the -1.29 M USD EBIT recorded in the previous year.

The Decision Diagnostics EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (k USD)
Date
EBIT (k USD)
Jan 1, 2013
-3,295.20 base
Jan 1, 2014
-1,271.26 base
Jan 1, 2015
-2,470.25 base
Jan 1, 2016
-3,008.39 base
Jan 1, 2017
-2,462.78 base
Jan 1, 2018
-1,854.06 base
Jan 1, 2019
-1,294.38 base
Jan 1, 2020
-2,101.43 base
YEAREBIT (k USD)
2020 -2,101.43
2019 -1,294.38
2018 -1,854.06
2017 -2,462.78
2016 -3,008.39
2015 -2,470.25
2014 -1,271.26
2013 -3,295.20
2012 -2,701.93
2011 -1,007.29
2010 784.00
2009 917.00
2008 660.00
2007 -1,130.00
Access this data via the Eulerpool API

Decision Diagnostics Revenue

Decision Diagnostics Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2013
1.44 M USD
-3.30 M USD
-7.95 M USD
Jan 1, 2014
426,525.00 USD
-1.27 M USD
-1.84 M USD
Jan 1, 2015
514,994.00 USD
-2.47 M USD
-2.77 M USD
Jan 1, 2016
1.09 M USD
-3.01 M USD
-3.18 M USD
Jan 1, 2017
1.88 M USD
-2.46 M USD
-2.99 M USD
Jan 1, 2018
2.24 M USD
-1.85 M USD
-2.24 M USD
Jan 1, 2019
2.38 M USD
-1.29 M USD
-3.13 M USD
Jan 1, 2020
1.98 M USD
-2.10 M USD
-29.67 M USD

Decision Diagnostics Margins

Decision Diagnostics stock margins

The Decision Diagnostics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Decision Diagnostics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Decision Diagnostics.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2013
74.06 %
-228.07 %
-550.28 %
Jan 1, 2014
35.88 %
-298.05 %
-431.63 %
Jan 1, 2015
57.10 %
-479.67 %
-538.13 %
Jan 1, 2016
22.61 %
-275.28 %
-290.99 %
Jan 1, 2017
11.50 %
-130.97 %
-159.08 %
Jan 1, 2018
34.90 %
-82.92 %
-100.19 %
Jan 1, 2019
35.74 %
-54.40 %
-131.65 %
Jan 1, 2020
25.18 %
-106.18 %
-1,499.05 %

Decision Diagnostics Stock analysis

What does Decision Diagnostics do? The Decision Diagnostics Corp, founded in 2002, is a company specializing in the manufacturing of medical diagnostic test kits and devices. The company is headquartered in Westlake Village, California, and operates production facilities in various parts of the world. The company's history began when the founders recognized a need for reliable, affordable, and easy-to-use diagnostic devices. This realization led to the development of the first product, the Shasta GenStrip. This test strip allowed patients to monitor their blood sugar levels at home, thereby better managing their diabetes. Since then, Decision Diagnostics Corp has become a leading provider of diagnostic test kits and devices. The company has several divisions, including the pharmaceutical division, the medical division, and the consumables division. In the pharmaceutical division, the company develops and produces tests for the pharmaceutical industry. These tests are used to assess the efficacy of new drugs and detect side effects. The medical division, on the other hand, focuses on developing diagnostic devices for various applications. This includes a test for detecting cancer markers in the blood or a test for assessing vitamin D levels. Another important division of the company is the consumables division. Here, the company provides test strips, syringes, needles, and other materials needed in medical practices and hospitals. The business model of Decision Diagnostics Corp is based on the idea that every person has the right to reliable medical care. Therefore, the company is committed to developing diagnostic devices and test kits that are easy to use and affordable. This allows patients to independently monitor their condition at home and take quick action if necessary. An example of this is the Shasta GenStrip, the first test strip developed by the company. This test strip allows patients to measure their blood sugar at home and better manage their diabetes. The Shasta GenStrip is compatible with common blood glucose meters and is significantly cheaper than comparable products. Another product developed in the medical division is the eScreen. This device allows for quick and reliable testing of urine samples for drugs or alcohol. The eScreen is primarily used in occupational medicine to ensure that employees are not using drugs. Overall, Decision Diagnostics Corp has become an important player in the medical industry. The company strives to provide patients with access to high-quality and affordable diagnostic devices and test kits. Through the constant development of innovative products, the company contributes to improving medical care worldwide. Decision Diagnostics is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Decision Diagnostics's EBIT

Decision Diagnostics's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Decision Diagnostics's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Decision Diagnostics's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Decision Diagnostics’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Decision Diagnostics stock

EBIT of Decision Diagnostics is -2.10 M USD in 2026.

EBIT of Decision Diagnostics changed from -1.29 M USD to -2.10 M USD, representing a 62.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Decision Diagnostics since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Decision Diagnostics historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Decision Diagnostics

All Key Metrics — Decision Diagnostics